Phase 2 Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You understand what the trial involves, agree to take part by signing a consent form, and are willing and able to follow the study plan
- You are between 18 and 70 years old (inclusive), of any gender
Who may not be able to join:
- You are pregnant, breastfeeding, or planning to become pregnant or breastfeed during the study
- All of the hair in the vitiligo-affected area on your face has turned white
- You are known or suspected to have an allergy to the active or inactive ingredients in the study drug (VC005) or similar medicines
- You have previously had any treatment aimed at removing skin pigment (colour)
- You have taken part in another clinical trial involving an experimental drug or medical device within roughly the past month, or within 5 half-lives of that drug — whichever is the longer period (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 15358160458
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage change in facial vitiligo area score index (F-VASI) relative to baseline at week 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.